Latest Breaking News On - மார்க்கர் சிகிச்சை - Page 1 : comparemela.com

Increased R&D Activities Have Fueled Growth and Promise for Pancreatic Cancer Treatment Financialnewsmedia.com News Commentary Share this article Share this article PALM BEACH,  Fla., May 20, 2021 /PRNewswire/ Sadly, for patients, the pancreatic cancer market has been steadily rising over the past several years and will most likely continue to grow over the next couple of years. Revenues will increase but so will money flow into R&D efforts to treat this condition. Pancreatic cancer is one of the most dangerous malignancies and is the fourth most common cause of cancer deaths in the U.S.  Increasing tobacco consumption, smoking, obesity, and growing awareness pertaining to various treatment options available are propelling the market growth at a global level. The peak incidence of pancreatic cancer is seen in the age group of 65 to 75 years. Thus, growing geriatric population is also expected to drive the growth during the forecast period. Furthermore, pancreatic cancer is ex

United-states
Texas
American
Devalingam-mahalingam
Ingmar-bruns
Peterl-hoang
American-society-of-clinical-oncology
Seelos-therapeutics-inc
American-society-of-gene-cell-therapy
Gene-therapy-at-baylor-college-of-medicine
Fn-media-group
Nasdaq